J. Safra Sarasin Holding AG purchased a new position in Deutsche Bank Aktiengesellschaft (NYSE:DB – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 82,789 shares of the bank’s stock, valued at approximately $2,396,000. Other institutional investors and hedge funds […]

J. Safra Sarasin Holding AG raised its stake in CF Industries Holdings, Inc. (NYSE:CF – Free Report) by 65.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,770 shares of the basic materials company’s stock after buying an additional 7,017 […]

J. Safra Sarasin Holding AG grew its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 4.4% in the first quarter, HoldingsChannel reports. The institutional investor owned 960,714 shares of the company’s stock after purchasing an additional 40,289 shares during the period. Merck & Co., Inc. makes up 2.0% of J. Safra Sarasin […]

J. Safra Sarasin Holding AG bought a new stake in Vanguard Industrials ETF (NYSEARCA:VIS – Free Report) in the first quarter, HoldingsChannel.com reports. The institutional investor bought 33,235 shares of the company’s stock, valued at approximately $10,377,000. Other hedge funds also recently made changes to their positions in the company. Hazlett Burt & Watson Inc. […]

J. Safra Sarasin Holding AG raised its stake in Xylem Inc. (NYSE:XYL – Free Report) by 5.6% in the 1st quarter, HoldingsChannel.com reports. The firm owned 332,132 shares of the industrial products company’s stock after buying an additional 17,640 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in Xylem were worth $39,632,000 as […]

J. Safra Sarasin Holding AG grew its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 8.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 336,967 shares of the company’s stock after acquiring an additional 25,665 shares during the quarter. AbbVie […]